These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 25549314

  • 1. Transcutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms and its impact on health-related quality of life in patients with Parkinson disease: a randomized controlled trial.
    Perissinotto MC, DʼAncona CA, Lucio A, Campos RM, Abreu A.
    J Wound Ostomy Continence Nurs; 2015; 42(1):94-9. PubMed ID: 25549314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M, Crampton J.
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S, Canbaz Kabay S, Cetiner M, Mestan E, Sevim M, Ayas S, Ozden H, Ozisik Karaman H.
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Transcutaneous tibial nerve stimulation versus parasacral stimulation in the treatment of overactive bladder in elderly people: a triple-blinded randomized controlled trial.
    Jacomo RH, Alves AT, Lucio A, Garcia PA, Lorena DCR, de Sousa JB.
    Clinics (Sao Paulo); 2020 Jan; 75():e1477. PubMed ID: 31939564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J, Connelly L, Dickson S, Duncan F, Lawrence M.
    Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transcutaneous tibial nerve home stimulation for overactive bladder in women with Parkinson's disease: A randomized clinical trial.
    Araujo TG, Schmidt AP, Sanches PRS, Silva Junior DP, Rieder CRM, Ramos JGL.
    Neurourol Urodyn; 2021 Jan; 40(1):538-548. PubMed ID: 33326648
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transcutaneous tibial nerve stimulation to treat urgency urinary incontinence in older women: 12-month follow-up of a randomized controlled trial.
    Schreiner L, Nygaard CC, Dos Santos TG, Knorst MR, da Silva Filho IG.
    Int Urogynecol J; 2021 Mar; 32(3):687-693. PubMed ID: 33057739
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R, Yildiz N, Alkan H.
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [Abstract] [Full Text] [Related]

  • 16. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
    Alomari MS, Abdulhamid AS, Ghaddaf AA, Alshareef KM, Haneef AK, AlQuhaibi MS, Banjar RA.
    Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L, Renson C, Van de Walle J, Everaert K, Spinoit AF.
    Trials; 2021 Apr 02; 22(1):247. PubMed ID: 33810804
    [Abstract] [Full Text] [Related]

  • 18. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C, Schneider T, Haab F, Sun F, Whelan L, Scholfield D, Dragon E, Mangan E.
    BJU Int; 2014 Sep 02; 114(3):418-26. PubMed ID: 24552358
    [Abstract] [Full Text] [Related]

  • 19. Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women.
    Schreiner L, dos Santos TG, Knorst MR, da Silva Filho IG.
    Int Urogynecol J; 2010 Sep 02; 21(9):1065-70. PubMed ID: 20458465
    [Abstract] [Full Text] [Related]

  • 20. Comparison of transcutaneous tibial nerve stimulation (TTNS) protocols for women with refractory overactive bladder (OAB): A prospective randomised trial.
    Alkis O, Sevim M, Güven Kartal İ, Baser A, İbrahim İvelik H, Aras B.
    Int J Clin Pract; 2021 Sep 02; 75(9):e14342. PubMed ID: 33966335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.